September 5, 2018
The end of an error. The Wall Street Journal reports that Theranos, the once-promising blood testing startup now plagued by scandals and lawsuits, will soon be shutting its doors for good. In a letter to shareholders obtained by the Journal, CEO and General Counsel David Taylor wrote that the company’s attempts to negotiate a sale transaction did not bear fruit, and that the company is in default...
October 18, 2016
Redwood City, California-based biotricity, which is working on a biometric remote monitoring solution, has received FDA clearance for the software component of their product.
The company’s first offering, which is slated for market launch later this year or early next year, is bioflux – a remote cardiac monitoring solution that includes a wearable heart monitor (to be worn on the torso) that uses...
September 29, 2016
Beginning this fall, Aetna will combine Apple’s consumer tech offerings with its analytics-based wellness and care management programs by integrating several iOS-exclusive health initiatives. First off, the company will make the Apple Watch available to some of its large employers and individual members during open enrollment season, and will be subsidizing part of the cost. Aetna will also be...
September 29, 2016
Dr. Mehmet Oz, a well-known television personality, has joined health technology startup iBeat as Special Advisor, in addition to making an investment in the company. The company makes a not-yet-launched smartwatch that offers continuous monitoring and analysis of heart rate, working to instantly detect signs of oncoming cardiac arrest. Oz, after reportedly seeing the potential impact of the...
August 3, 2016
Here are all the digital health deals, partnerships, and customer wins that MobiHealthNews has tracked over the past two weeks.
UK-based pharmaceutical giant GlaxoSmithKline partnered with South San Francisco-based Verily to create Galvani Bioelectronics – a joint venture to develop implantable bioelectric medicines, a branch of medicine that works to fight diseases by targeting electrical...
June 16, 2016
Digital entrepreneur and former Health 2.0 staffer Jean Luc Neptune announced on Twitter that he'd be leaving his position as Accelerator Director at Blueprint Health at the end of the month. He said, however, he'd remain a partner in Blueprint Health LLC and its investment fund.
This one is, admittedly, a stretch for a list of "recent" digital health departures, but important: At the end of...